References

• 1970Manual for the State-Trait Anxiety Inventory24,983 cited
• 1983The Brief Symptom Inventory: an introductory report6,647 cited
• 2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance1,682 cited
• 2008Human hallucinogen research: guidelines for safety1,201 cited
• 2011Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects932 cited
• 1998The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans577 cited
• 2010Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies531 cited
• 1994Dose-Response Study of N,N-Dimethyltryptamine in Humans454 cited
• 2001Dimensions of the Mysticism Scale: Confirming the Three‐Factor Structure in the United States and Iran225 cited
• 2005Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors196 cited
• 2006Pattern of use and subjective effects of Salvia divinorum among recreational users163 cited
• 2003Salvinorin A: the ‘magic mint’ hallucinogen finds a molecular target in the kappa opioid receptor153 cited
• 2007Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement